Masayuki Nagahashi

10PUBLICATIONS
10CO-AUTHORS
Cancer geneticsTumour immunologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 29, 2026
VAF-tumor content graph: a simple visual framework for interpreting hereditary cancer variants and supporting genetic counseling in tumor-only sequencing.

|Feb 23, 2026
Prognostic significance of peripheral myeloid-derived suppressor cells in advanced breast cancer.

Haruka Kanaoka, Masayuki Nagahashi, Junko Tsuchida

|Nov 05, 2025
Targeting Interleukin-6 as a Novel Strategy to Overcome Eribulin Resistance in Breast Cancer.

Akira Hattori, Masayuki Nagahashi, Miki Komatsu

|Jun 18, 2025
An Acrolein-Based Drug Delivery System Enables Tumor-Specific Sphingosine-1-Phosphate Targeting in Breast Cancer without Lymphocytopenia.

Masayuki Nagahashi, Miki Komatsu, Sayaka Urano

|Feb 05, 2025
Breast cancer statistics for Japan in 2022: annual report of the national clinical database-breast cancer registry-clinical implications including chemosensitivity of breast cancer with low estrogen receptor expression.

Masayuki Nagahashi, Hiraku Kumamaru, Naoko Kinukawa

|Jan 14, 2025
Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy.

Masayuki Nagahashi, Eri Ishikawa, Takahiro Nagai

Pageof 2

Frequent Collaborators

1 joint publications

Kazuaki Takabe

1 joint publications

Miki Komatsu

1 joint publications

Sayaka Urano

1 joint publications

Mamiko Kuroiwa